{"id":43704,"date":"2019-12-26T12:29:00","date_gmt":"2019-12-26T20:29:00","guid":{"rendered":"http:\/\/www.kentreporter.com\/news\/keiser-files-bills-to-take-on-high-prescription-drug-prices\/"},"modified":"2019-12-26T12:32:24","modified_gmt":"2019-12-26T20:32:24","slug":"keiser-files-bills-to-take-on-high-prescription-drug-prices","status":"publish","type":"post","link":"https:\/\/www.kentreporter.com\/news\/keiser-files-bills-to-take-on-high-prescription-drug-prices\/","title":{"rendered":"Keiser files bills to take on high prescription drug prices"},"content":{"rendered":"
State Sen. Karen Keiser, D-Des Moines, has filed a suite of bills to rein in sharply rising prescription drug prices.<\/p>\n
“This is a crisis,” said Keiser in a media release. “My colleagues and I hear every day from constituents who can’t afford their medication anymore, people who have to choose between prescriptions and rent.<\/p>\n
“We have a responsibility to curb excessive costs of critical prescription drugs that are vital for people’s health. I’m working together with stakeholders to take several steps to make crucial, life-sustaining medications more affordable.”<\/p>\n
Keiser has pre-filed five bills to tackle the problem from multiple angles. The bills will be considered during the 2020 legislation session, which begins on Jan. 13 in Olympia.<\/p>\n
• SB 6087 would cap the out-of-pocket cost to patients for insulin at $100 per month.<\/p>\n
• SB 6088 would establish a prescription drug affordability board that would review prices to see if maximum price caps are needed.<\/p>\n
• SB 6110 would provide a mechanism for the state to import prescription drugs from Canada under a federal waiver.<\/p>\n
• SB 6111 would allow the state to contract with Canadian pharmacies that state employees could use for their needed high-cost medications.<\/p>\n
• SB 6113 would create a centralized purchasing process for insulin, based on the approached used by the state to purchase childhood vaccines.<\/p>\n
Keiser is also continuing work to update a bill passed last year, HB 1224, that was supposed to provide drug price transparency, but has yet to be fully implemented.<\/p>\n
“I expect lots of pushback from lobbyists and the companies that are profiting from high prescription drug prices,” said Keiser. “But this is too important to wait.”<\/p>\n","protected":false},"excerpt":{"rendered":"
Legislature to consider in 2020 <\/p>\n","protected":false},"author":106,"featured_media":43705,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[9,4],"tags":[],"yst_prominent_words":[],"class_list":["post-43704","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-home","category-news"],"_links":{"self":[{"href":"https:\/\/www.kentreporter.com\/wp-json\/wp\/v2\/posts\/43704"}],"collection":[{"href":"https:\/\/www.kentreporter.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.kentreporter.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.kentreporter.com\/wp-json\/wp\/v2\/users\/106"}],"replies":[{"embeddable":true,"href":"https:\/\/www.kentreporter.com\/wp-json\/wp\/v2\/comments?post=43704"}],"version-history":[{"count":0,"href":"https:\/\/www.kentreporter.com\/wp-json\/wp\/v2\/posts\/43704\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.kentreporter.com\/wp-json\/wp\/v2\/media\/43705"}],"wp:attachment":[{"href":"https:\/\/www.kentreporter.com\/wp-json\/wp\/v2\/media?parent=43704"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.kentreporter.com\/wp-json\/wp\/v2\/categories?post=43704"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.kentreporter.com\/wp-json\/wp\/v2\/tags?post=43704"},{"taxonomy":"yst_prominent_words","embeddable":true,"href":"https:\/\/www.kentreporter.com\/wp-json\/wp\/v2\/yst_prominent_words?post=43704"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}